Consolidated Statements of Operations and Comprehensive loss - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Operating expenses
General and administrative	$ 11,605,761	$ 20,499,052
Research and development	8,027,773	4,788,807
Impairment of intangible assets and goodwill	7,453,662	38,678,918
Depreciation and amortization	327,910	656,643
Total operating expenses	27,415,106	64,623,420
Loss from operations	(27,415,106)	(64,623,420)
Other income (expense)
Inducement expense		(1,125,291)
Change in fair value of warrant liabilities	4,315,236	9,327,326
Change in fair value of investment option liability	3,472,726
Change in fair value of derivative liability	(325,000)
Interest expense	(5,249)	(10,316)
Total other income	7,457,713	8,191,719
Net loss before income taxes	(19,957,393)	(56,431,701)
Income tax benefit	1,486,060	7,454,805
Net loss	(18,471,333)	(48,976,896)
Less preferred dividends attributable to non-controlling interest	33,014
Less deemed dividends attributable to accretion of embedded derivative at redemption value	295,976
Net loss attributable to shareholders	(18,800,323)	(48,976,896)
Other comprehensive loss
Foreign currency translation	(505,932)	150,475
Comprehensive loss	$ (19,306,255)	$ (48,826,421)
Net loss per share - basic and diluted	$ (13.00)	$ (103.69)
Weighted average shares outstanding, basic and diluted	1,446,007	472,343